Method for preparing 2-oxo-4-(hydroxy(methyl)phosphono)butyric acid

PPO is prepared by oxidizing diols or hydroxymethyl ketones with enzymes or chemical catalysts, which solves the problems of complexity and danger in existing glufosinate production methods, realizes safe and efficient PPO production, and improves the production efficiency and yield of glufosinate.

CN123076602APending Publication Date: 2026-11-10BASF AGRO TRADEMARKS GMBH
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
CN202580027728.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2024-04-15
Filing Date
2025-04-11
Publication Date
2026-11-10

AI Technical Summary

Technical Problem

Existing glufosinate production methods are complex, dangerous, and inefficient, making it difficult to efficiently produce pure L-glufosinate or D-glufosinate mixtures rich in L-glufosinate. In particular, the presence of the highly toxic intermediate acryloyl cyanide leads to increased safety risks and costs.

Method used

2-O-4-(hydroxy(methyl)phosphono)butyric acid (PPO) is prepared by oxidation of diols or hydroxymethyl ketones in the presence of enzymes or chemical catalysts. Oxidoreductase EC1 or platinum group metal catalysts, catalase and activators are used to avoid tar formation and improve yield.

Benefits of technology

This has enabled a safe and easy-to-operate PPO production method, which has improved the efficiency and yield of glufosinate production while reducing safety risks and costs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123076602A_ABST
    Figure CN123076602A_ABST
Patent Text Reader

Abstract

A method for preparing 2-oxo-4-(hydroxy(methyl)phosphono)butyric acid (PPO) having formula (I), (I), the method comprising oxidizing a diol having formula (IIa), (IIa), and / or a hydroxymethyl ketone according to formula (IIb) in an oxidation step: (IIb). (I)(IIa)(IIb).
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to a method for preparing 2-oxo-4-(hydroxy(methyl)phosphono)butyric acid (PPO). In particular, this invention relates to the catalytic oxidation of a diol precursor to 2-oxo-4-(hydroxy(methyl)phosphono)butyric acid (PPO). Background Technology

[0002] Glufosinate is a non-selective foliar herbicide and is considered one of the safest herbicides from a toxicological or environmental perspective. Current commercial chemical synthesis methods for glufosinate produce a racemic mixture of L- and D-glufosinate (Duke et al. 2010 Toxins 2:1943-1962). However, L-glufosinate (also known as phosphinic acid or (S)-2-amino-4-(hydroxy(methyl)phosphono)butyric acid) is significantly more effective than D-glufosinate (Ruhland et al. (2002) Environ. Biosafety Res. 1:29-37).

[0003] Therefore, there is a need for methods to produce only or primarily the active form of L-glufosinate. Previously, there were no cost-effective methods to generate pure L-glufosinate or a mixture of L-glufosinate-rich D-glufosinate and L-glufosinate. Therefore, efficient reactions for the production of L-glufosinate have been developed, as proposed in WO 2017 / 151573 A1. This reaction route uses 2-oxo-4-(hydroxy(methyl)phosphono)butyric acid (PPO) as an intermediate. The synthetic route for PPO has been further investigated, particularly in EP 0 030 424 B1.

[0004] WO 2024 / 051121 A1 discloses a method for preparing the biocidal intermediate 4-(hydroxymethylphosphono)-2-carbonylbutyric acid (PPO). However, the disclosed method includes a step of mixing acryloyl chloride, a first solvent, a polymerization inhibitor, a catalyst, and potassium ferrocyanide. This reaction results in the formation of acryloyl cyanide, a highly toxic compound that can be absorbed through the skin, mouth, and inhalation. Therefore, the industrial application of this method requires reliable safety protocols and measures to ensure compliance with them. This makes the entire method complex, error-prone, expensive, and still carries inherent risks. Summary of the Invention

[0005] Therefore, the efficiency of PPO production methods can always be improved. Improving the efficiency of PPO production methods will also improve the overall efficiency of glufosinate production, especially L-glufosinate.

[0006] Therefore, the object of the present invention is to provide a method for producing PPO that is easy to perform, has good yield, is easy to post-process, and has readily available starting materials.

[0007] It has now been discovered that the above objective can be achieved by a method for preparing 2-oxo-4-(hydroxy(methyl)phosphono)butyric acid (PPO) and / or PPO salts, more particularly PPO-sodium or PPO-ammonium, according to formula (I):

[0008] (I)

[0009] The method includes oxidizing a diol having formula (IIa) in an oxidation step:

[0010] (IIa)

[0011] And / or hydroxymethyl ketones according to formula (IIb):

[0012] (IIb).

[0013] It has been further and unexpectedly discovered that the above-mentioned objective can be achieved by using a mixture comprising the following for the preparation of glufosinate and / or glufosinate salts, more particularly glufosinate, glufosinate sodium or glufosinate ammonium: 2-oxo-4-(hydroxy(methyl)phosphono)butyric acid (PPO) according to formula (I):

[0014] (I),

[0015] And additionally, diols according to formula (IIa):

[0016] (IIa)

[0017] And / or hydroxymethyl ketones according to formula (IIb):

[0018] (IIb).

[0019] Finally, it has been unexpectedly discovered that the above objective can be achieved by using a mixture for preparing glufosinate and / or glufosinate salts, more particularly glufosinate, glufosinate sodium, or glufosinate ammonium, the mixture comprising 2-oxo-4-(hydroxy(methyl)phosphono)butyric acid (PPO) according to formula (I).

[0020] (I),

[0021] And additionally, diols according to formula (IIa):

[0022] (IIa)

[0023] And / or hydroxymethyl ketones according to formula (IIb):

[0024] (IIb).

[0025] definition

[0026] As used in this specification and the appended claims, unless the context clearly specifies otherwise, the singular form “a / an” also includes the corresponding plural. In the context of this invention, the terms “about” and “approximately” indicate a range of precision that, as will be understood by those skilled in the art, still ensures the technical effect of the features discussed. This term typically indicates a deviation from the indicated numerical value by ±20%, preferably ±15%, more preferably ±10%, and even more preferably ±5%. It should be understood that the term “comprising” is not restrictive. For the purposes of this invention, the term “consisting of” is considered a preferred embodiment of the term “formed by”. If a group is defined below as including at least a certain number of embodiments, this means that a group preferably consisting only of those embodiments is also covered. Furthermore, the terms “first,” “second,” “third,” or “(a),” “(b),” “(c),” “(d),” etc., in the specification and claims are used to distinguish similar elements and are not necessarily used to describe a sequential or chronological order. It should be understood that the terms thus used are interchangeable where appropriate, and the embodiments of the invention described herein can operate in orders other than those described or shown herein. In cases where the terms "first," "second," "third," or "(a)," "(b)," "(c)," "(d)," "i," "ii," etc., refer to steps of a method, use, or experiment, there is no temporal or time interval continuity between these steps, unless otherwise indicated as set forth in this application above or below. That is, these steps may be performed simultaneously, or there may be time intervals of seconds, minutes, hours, days, weeks, months, or even years between such steps. It should be understood that the invention is not limited to the specific methods, schemes, reagents, etc., described herein, as these can vary. It should also be understood that the terminology used herein is for the purpose of describing specific embodiments only and is not intended to limit the scope of the invention, which will be limited only by the appended claims. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art.

[0027] As used herein, the terms “does not contain / comprise” or “does not contain…” in the context mean that the compositions of the present invention do not contain a specific compound or group of compounds (which may be grouped together under a certain set of terms), and that the compositions do not contain more than 0.8% of the compound or group of compounds by weight based on the total weight of the compositions. Furthermore, it is preferred that the compositions according to the present invention do not contain more than 0.5% of the compound or group of compounds by weight, and preferably the compositions do not contain the compound or group of compounds at all.

[0028] As used herein, the term "platinum group metals" refers to the chemically closely related metals platinum, palladium, iridium, rhodium, ruthenium, and osmium, which typically coexist together. The use of platinum or palladium, especially platinum, is preferred.

[0029] As used herein, the term "aqueous alkaline medium" refers to a reaction mixture that induces an alkaline reaction, i.e., the reaction mixture has a pH value greater than 7. Detailed Implementation

[0030] As described above, the present invention relates to a method, use and mixture, which will be described in more detail below.

[0031] The method of the present invention

[0032] This invention relates to a method for preparing 2-oxo-4-(hydroxy(methyl)phosphono)butyric acid (PPO) having formula (I).

[0033] (I)

[0034] The method includes oxidizing a diol having formula (IIa) in an oxidation step (O).

[0035] (IIa)

[0036] And / or hydroxymethyl ketones according to formula (IIb):

[0037] (IIb).

[0038] This method makes it easy to obtain PPO because the diol can be produced, for example, by adding the methylphosphinic acid butyl ester radical to 3,4-dihydroxybutene or its acetylated derivative and then subjecting it to acidic deprotection.

[0039] The oxidation step of the method according to the invention can be carried out in the presence of a chemical catalyst (OC) or an enzyme (OE).

[0040] Methods using the oxidation step in the presence of an enzyme (OE).

[0041] In the following, preferred embodiments of the invention are described, wherein the oxidation step (O) is carried out in the presence of an enzyme (OE).

[0042] Preferably, if an enzyme is used in the method according to the invention, the enzyme present in the oxidation step (OE) is an oxidoreductase EC1 enzyme. More preferably, the oxidoreductase EC1 enzyme is selected from the group consisting of: EC1.1, EC1.2, or EC1.10, more preferably EC1.1.1, EC1.1.3, EC1.2.1, and EC1.2.3. Most preferably, the oxidoreductase EC1 enzyme is the enzyme according to SEQ ID NO: 10. Preferably, not only one enzyme can be used, but also a combination of oxidoreductase EC1 enzymes can be used, preferably a combination of EC1.1 and EC1.2 classes.

[0043] If the method according to the invention is carried out using an enzyme, the oxidation step (OE) of the method is preferably carried out at a temperature in the range of 25°C to 45°C, more preferably 30°C to 42°C, and most preferably 35°C to 40°C. Also preferably, if the method according to the invention is carried out using an enzyme, the oxidation step (OE) of the method is carried out in an aqueous solution, preferably a buffered aqueous solution. Most preferably, the pH of the buffered aqueous solution is in the range of 8.8 to 7.2, and most preferably, the pH of the buffered aqueous solution is 7. Preferably, the buffered aqueous solution is a solution of ammonia in water or a solution of isopropylamine in water. Furthermore, if the method according to the invention is carried out using an enzyme, the oxidation step (OE) of the method is carried out for a period of 5 to 48 hours.

[0044] Preferably, the oxidation step (OE) is carried out in an in vitro environment. In the case where the oxidation step in the method of the present invention is an oxidation step (OE) in the presence of an enzyme, preferably the oxidoreductase EC1 enzyme, the entire method according to the present invention is carried out in an in vitro environment.

[0045] The oxidation step (OE) of the method of the present invention is preferably carried out in the presence of catalase other than the oxidoreductase EC1, preferably catalase according to CAS number 9001-05-2. It has been unexpectedly found that the presence of catalase significantly increases the yield of the compound according to formula (I). Without wishing to be bound by theory, it is believed that the increase in yield is caused by the removal of intermediately formed hydrogen peroxide from the reaction mixture during the oxidation step.

[0046] Methods using oxidation steps in the presence of a chemical catalyst (OC).

[0047] In the following, alternatively preferred embodiments are described, wherein the oxidation step (O) is carried out in the presence of a chemical catalyst (OC).

[0048] Therefore, if the method according to the invention is carried out in the presence of a chemical catalyst, the chemical catalyst for the oxidation step (OC) is preferably a platinum group metal catalyst. More preferably, the oxidation step (OC) is carried out in an aqueous solution in the presence of a gas containing molecular oxygen and an activator. More preferably, the oxidation step (OC) is carried out in an alkaline aqueous solution in the presence of a gas containing molecular oxygen and an activator.

[0049] The platinum group metals used as catalysts in the oxidation step (OC) can be added to the reactants in various forms, such as in elemental form, i.e., metallic form (e.g., as so-called "ferrous metals"), in combination with other platinum group metals, or in the form of compounds (e.g., as oxides or also in the form of some other compounds). Preferably, the platinum group metals used as catalysts in the oxidation step (OC) are in metallic form. Preferably, the platinum group metal catalyst used as a catalyst in the oxidation step (OC) is selected from platinum and palladium.

[0050] The platinum group metals used as catalysts in the oxidation step (OC) can be applied to a support. Preferably, the support for the platinum group metal catalyst used in the oxidation step (OC) is selected from the group consisting of activated carbon, graphite, diatomaceous earth, silica gel, spinel, alumina, asbestos, calcium carbonate, magnesium carbonate, barium sulfate, or organic support materials. Activated carbon has proven to be particularly suitable; for example, inexpensive powdered activated carbon produced from wood is widely used for decolorization purposes. Therefore, preferably, the platinum group metal catalyst used in the oxidation step (OC) of the method according to the invention is a supported platinum group metal catalyst, more preferably a carbon-supported platinum group metal catalyst.

[0051] The amount of platinum group metals contained in the supported platinum group metal catalyst used in the oxidation step (OC) of the method according to the invention can be less than 10 wt.-% relative to the total weight of the platinum group metal catalyst, preferably in the range of 0.1 to 5 wt.-%.

[0052] Furthermore, the platinum group metal catalyst used in the oxidation step (OC) of the method according to the invention preferably contains an activator. More preferably, the activator is selected from lead and / or its compounds, and / or bismuth and / or its compounds.

[0053] The amount of platinum group metal catalyst used in the oxidation step (OC) of the method according to the invention depends on the desired oxidation rate, the form of the catalyst, the nature and amount of the activator, etc., and can be readily determined by preliminary experiments under certain circumstances.

[0054] Preferably, in the oxidation step (OC) of the method according to the invention, the amount of platinum group metal used per mole of the compound according to formula (IIa) or (IIb) is less than 1,000 mg. In most cases, a sufficiently high reaction rate is achieved with an amount of 20 to 400 mg of platinum group metal per mole of the compound according to formula (IIa) or (IIb).

[0055] It has been found that tar formation is avoided when a platinum group metal catalyst is used in the oxidation step (OC) of the method according to the invention. Therefore, the platinum group metal catalyst used in the oxidation step (OC) of the method according to the invention can be reused. Due to this reuse, the consumption of platinum group metal catalyst per mole of a compound according to formula (IIa) or (IIb) can be reduced to 5 mg or less before reprocessing of the platinum group metal catalyst is required.

[0056] Preferably, in the oxidation step (OC) of the method according to the invention, the activator is used in an amount of less than 0.1 moles or more, more preferably 5 x 10 moles, relative to the compound according to formula (IIa) or (IIb). -5 Up to 1 x 10 -1 moles, or even more preferably 1 x 10 -4 Up to 1 x 10 -2 The amount of moles exists.

[0057] The activator used in the oxidation step (OC) of the method according to the invention preferably includes: metallic lead and / or bismuth itself, that is, lead and / or bismuth in elemental form; and / or lead and / or bismuth in the form of its compounds, such as lead and / or bismuth as oxides; or lead and / or bismuth as salts of hydroacids (such as chlorides, bromides, iodides, sulfides, selenides, and tellurides); or as salts of inorganic oxyacids (such as nitrates, nitrites, phosphites, phosphates, sulfates, carbonates, perchlorates, antimonates, and arsenates). Lead and / or bismuth as salts of oxoacids derived from transition metals (e.g., vanadates, niobates, tantalates, chromates, molybdates, tungstates, and permanganates); or as salts of organic aliphatic or aromatic acids (e.g., formates, acetates, propionates, benzoates, salicylates, lactates, mandelates, glyoxylates, arylglyoxylates, and citrates); or as phenolates, etc. In each specific case, the activator may be soluble, partially soluble, or insoluble in the reaction mixture.

[0058] Therefore, the activator used in the oxidation step (OC) of the method according to the invention preferably comprises one or more compounds selected from the group consisting of lead in elemental form, bismuth in elemental form, lead in oxide form, bismuth in oxide form, lead in hydroate form, bismuth in hydroate form, lead in salt form of inorganic oxyacid, bismuth in salt form of inorganic oxyacid, lead in salt form of transition metal oxyacid, bismuth in salt form of transition metal oxyacid, lead in salt form of organic aliphatic or aromatic acid, and bismuth in salt form of organic aliphatic or aromatic acid, more preferably selected from lead in elemental form and bismuth in elemental form, and most preferably bismuth in elemental form.

[0059] In a preferred embodiment of the method according to the invention, in the oxidation step (OC), these activators may also be used in combination with each other and / or with other elements or compounds (not specified as activators). Activators used in the oxidation step (OC) of the method according to the invention may be present at various oxidation state levels or as mixtures of various oxidation state levels. Furthermore, changes in oxidation state may occur during the reaction. If the activators have not yet been added as oxides and / or hydroxides, they may be completely or partially converted to these oxides and / or hydroxides in an alkaline medium. After the reaction, the platinum group metal catalyst can be filtered out along with the slightly soluble activator and reused in subsequent oxidation reactions. If losses of platinum group metal catalysts and / or activators occur, these losses must be compensated.

[0060] The activator used in the oxidation (OC) step of the method according to the invention can be added to the reactants as a solid, preferably in a finely dispersed form, or in solution form. The activator can also be added during the preparation of the platinum group metal catalyst, or impregnated with the activator. The activator can also act as a support for platinum metal. Preferably, the activator is incorporated into the platinum group metal catalyst.

[0061] If the oxidation step (OC) of the method according to the invention is carried out in the presence of a chemical catalyst, then the oxidation step (OC) is preferably carried out in the presence of an aqueous alkaline medium.

[0062] The alkali of the aqueous alkaline medium in the oxidation step (OC) of the method according to the invention can be added to a solution or suspension of the compound according to formula (IIa) or (IIb) in water, or the compound according to formula (IIa) or (IIb) can be dissolved or suspended in an alkaline aqueous solution. Preferably, the amount of alkali is selected to provide 0.3 to 5 equivalents, preferably 0.5 to 3 equivalents, of alkali per mole of the compound according to formula (IIa) or (IIb) to be oxidized. Particularly preferred is the use of 0.9 to 2 equivalents of alkali per mole of the compound according to formula (IIa) or (IIb) to be oxidized.

[0063] Preferably, the base is selected from a list of sodium hydroxide, potassium hydroxide, or carbonates; more preferably, the base is selected from a list of sodium hydroxide or potassium hydroxides; and most preferably, the base is sodium hydroxide.

[0064] In the oxidation step (OC) of the method according to the invention, the concentration of the organic compounds in the aqueous alkaline reaction solution is typically selected such that the diol of formula (IIa), the ketone of formula (IIb), and the PPO of formula (I) are present in solution under the reaction conditions. Where appropriate, the diol of formula (IIa) and / or the ketone of formula (IIb) should be added to the oxidation mixture in portions, preferably together with a portion of the base. Most preferably, the final concentration of the organic compounds in the reaction mixture is in the range of 5 to 30 wt.% relative to the total weight of the oxidation mixture.

[0065] Under the conditions according to the invention, oxidation can be observed at all temperatures where a liquid phase is present. Therefore, the possible reaction temperature range for the oxidation step (OC) according to the method is from the freezing point to the boiling point of the reaction mixture. Preferably, if the oxidation step is carried out in the presence of a chemical catalyst, the oxidation step (OC) is carried out at a temperature of 10°C to 100°C, preferably 25°C to 85°C, and most preferably 45°C to 65°C.

[0066] The venting step in the oxidation (OC) step of the method according to the invention can be carried out by bubbling a gas containing molecular oxygen through the reaction mixture. Alternatively, the gas containing molecular oxygen can be applied at a pressure of 0.5 to 10 atm.

[0067] Preferably, the gas containing molecular oxygen used, such as in the oxidation step (OC) of the method according to the invention, can be pure oxygen or air.

[0068] When carried out in the presence of a chemical catalyst, preferably a platinum group metal catalyst, the oxidation step of the method of the present invention is preferably carried out in the presence of catalase, preferably catalase according to CAS number 9001-05-2. It has been unexpectedly found that the presence of catalase significantly increases the yield of the compound according to formula (I). Without wishing to be bound by theory, it is believed that the increase in yield is caused by the removal of intermediately formed hydrogen peroxide from the reaction mixture during the oxidation step.

[0069] If catalase is present in the reaction mixture during the oxidation step (OC) of the method of the present invention when carried out in the presence of a chemical catalyst, preferably a platinum group metal catalyst, the reaction temperature is preferably in the range of 25°C to 45°C, more preferably 30°C to 42°C, and most preferably 35°C to 40°C.

[0070] Uses of the present invention

[0071] Furthermore, the present invention relates to the use of mixtures for the preparation of glufosinate and / or glufosinate salts, more particularly glufosinate, glufosinate sodium or glufosinate ammonium, the mixture comprising 2-oxo-4-(hydroxy(methyl)phosphono)butyric acid (PPO) according to formula (I).

[0072] (I),

[0073] And additionally, diols according to formula (IIa)

[0074] (IIa),

[0075] And / or hydroxymethyl ketones according to formula (IIb):

[0076] (IIb).

[0077] Specifically, PPO is preferably used to produce glufosinate, preferably L-glufosinate, by amination with a transaminase (TA), by amination with an L-amino acid dehydrogenase (LAAD), or by chemical conversion. Preferably, PPO is used to produce glufosinate, preferably L-glufosinate, by amination with a transaminase (TA) or by amination with an L-amino acid dehydrogenase (LAAD). If PPO is used to produce glufosinate, preferably L-glufosinate, by amination with a transaminase (TA), the amination is preferably carried out in the presence of an amine group from one or more amine donors. If PPO is used to produce glufosinate, preferably L-glufosinate, by amination with an L-amino acid dehydrogenase (LAAD), the amination is preferably carried out in the presence of an ammonia source.

[0078] The mixture of the present invention

[0079] Finally, the present invention relates to a mixture comprising 2-oxo-4-(hydroxy(methyl)phosphono)butyric acid (PPO) according to formula (I).

[0080] (I),

[0081] And additionally, diols according to formula (IIa)

[0082] (IIa),

[0083] And / or hydroxymethyl ketones according to formula (IIb):

[0084] (IIb).

[0085] In a preferred embodiment, the present invention relates to a mixture comprising 2-oxo-4-(hydroxy(methyl)phosphono)butyric acid (PPO) according to formula (I).

[0086] (I),

[0087] And additionally, diols according to formula (IIa)

[0088] (IIa),

[0089] And hydroxymethyl ketones according to formula (IIb):

[0090] (IIb).

[0091] It has been found that the mixture can be used to produce glufosinate, preferably L-glufosinate, by amination of PPO to L-glufosinate with transaminase (TA), by amination of PPO to L-glufosinate with L-amino acid dehydrogenase (LAAD), or by chemical conversion. Preferably, the mixture can be used to produce glufosinate, preferably L-glufosinate, by amination of PPO to L-glufosinate with transaminase (TA) or by amination of PPO to L-glufosinate with L-amino acid dehydrogenase (LAAD). If the mixture is used to produce glufosinate, preferably L-glufosinate, by amination of PPO to L-glufosinate with transaminase (TA), the amination is preferably carried out in the presence of an amine group from one or more amine donors. If the mixture is used to produce glufosinate, preferably L-glufosinate, by amination of PPO to L-glufosinate with L-amino acid dehydrogenase (LAAD), the amination is preferably carried out in the presence of an ammonia source.

[0092] Preferably, PPO is the main compound in the mixture according to the invention.

[0093] Preferably, based on the combined weight of PPO, the diol according to formula (IIa) and the ketone according to formula (IIb), the amount of PPO in the mixture according to the invention is 80% or more, 85% or more, 90% or more, or about 95% or more, 97% or more, or 98% or more.

[0094] Preferably, based on the combined weight of PPO, the diol according to formula (IIa), and the ketone according to formula (IIb), the amount of the diol according to formula (IIa) in the mixture according to the invention is 10% or less, 5% or less, 2.5% or less, or 1% or less.

[0095] Preferably, based on the combined weight of PPO, the diol according to formula (IIa), and the ketone according to formula (IIb), the amount of the ketone according to formula (IIb) in the mixture according to the invention is 10% or less, 5% or less, 2.5% or less, or 1% or less.

[0096] These compositions may optionally be present as a dry powder or dissolved in an aqueous or non-aqueous carrier, and may optionally contain additional chemical substances. Optionally, the compositions are prepared and used in an in vitro environment.

[0097] Example

[0098] Example IE1 of this invention

[0099]

[0100] 1 M NaOH was added to a solution of 100 mg of 2-hydroxy-4-(hydroxy(methyl)phosphono)butanol in 6 mL of water to adjust the pH to 8. 500 mg of carbon-supported Pt / Bi (Pt / Bi on carbon) (59% water, 1.63% Pt, 0.41% Bi) was added. The reaction mixture was heated to 55°C, and the pH was adjusted to 8 throughout the reaction by adding aqueous NaOH while purging with oxygen. After 28 h, NMR showed a 10% conversion to keto acid (PPO). PPO and the intermediate were identified by both NMR and HPLC.

[0101] HPLC method: Phosphorus-containing compounds were separated by the following method: Aminex HPX-87 H, 300 7.8 mm column, temperature 30°C, flow rate 0.5 mL / min, RI detection, eluent 5 mM sulfuric acid in water. HPLC retention times: 2-hydroxy-4-(hydroxy(methyl)phosphono)butanol: 16.0 min, PPO: 9.7 min.

[0102] Example of this invention IE2

[0103]

[0104] 1 M NaOH was added to a solution of 100 mg of 2-hydroxy-4-(hydroxy(methyl)phosphono)butanol in 6 mL of water to adjust the pH to 8. 500 mg of carbon-supported Pt / Bi (59% water, 1.63% Pt, 0.41% Bi) was added. Catalase (10 mg, CAS: 9001-05-2) was added to the reaction mixture. The reaction mixture was heated to 40°C and aerated. The pH was adjusted to 8 by adding aqueous NaOH throughout the reaction. After 26 h, the conversion to keto acid (PPO) was measured by NMR to be 59%.

[0105] Example of this invention: Cloning of IE3-oxidoreductase

[0106] Enzymes were identified from public databases (NCBI, Uniprot). The DNA sequences corresponding to these enzymes were codon-optimized for expression in *Escherichia coli* (E. coli) and cloned (Twist Bioscience) into the pDHE 19.2 vector (DE 19848129). The target gene was controlled by the rhamnose-inducible promoter (rhaBAD). The synthesized plasmid was used to transform competent cells of *E. coli* strain TG10 (WO 2004 / 050877 A1) (Chung, CT et al., *Proc Natl Acad Sci USA*, 1989, 86, 2172). Escherichia coli strain TG10 is an rhaA- derivative of Escherichia coli TG1 (DSMZ 6056) transformed with pHSG575 (Takeshita, S. et al., Gene, 1987, 61, 63) and pAgro4 (pBB541 in Tomoyasu, T. et al., Mol. Microbiol., 2001, 40, 397). GalOx (SEQ ID NO:9) can be cloned and expressed as in Birmingham, WR et al., Nature Communications, 2021, 12, 4946 or WO 2016 / 150629 A1. The sequences listed in Table 1 were cloned based on the above protocol.

[0107] Table 1: Enzymes tested

[0108]

[0109] Example of this invention: Recombinant production of IE4-oxidase

[0110] Escherichia coli TG10 transformed with an oxidase-containing plasmid was grown at 37°C for 16 h (200 rpm) in 10 ml LB medium supplemented with 100 µg / ml ampicillin, 50 µg / ml spectinomycin, 20 µg / ml chloramphenicol, and 12.5 µg / ml tetracycline. This preculture was used to inoculate 100 ml of LB medium supplemented with 100 µg / ml ampicillin, 50 µg / ml spectinomycin, 20 µg / ml chloramphenicol, and 12.5 µg / ml tetracycline until the optical density reached 0.6 at A600 nm. Add 0.2 mM isopropyl-β-D-thiogalactopyranoside and 0.5 g / L rhamnose to the culture and incubate further at 22°C for 16–18 h (200 rpm). [The text then abruptly shifts to a seemingly unrelated topic:] By adding 0.2 mM isopropyl-β-D-thiogalactopyranoside and 0.5 g / L rhamnose to the culture, and further incubating at 22°C for 16–18 h (200 rpm), the culture was further incubated. Biomass was harvested by centrifugation for 15 min and the pellets were frozen at -20°C until further use. Recombinant production of GalOx (SEQ ID NO:10) is described in Birmingham, WR et al., Nature Communications, 2021, 12, 4946 or WO 2016 / 150629 A1.

[0111] Example 5 of this invention - Preparation of biocatalysts

[0112] Thaw the frozen clumps in 0.1 M potassium phosphate buffer (pH 7.8) (3 mL buffer / g clump). Distribute the cell suspension into 2 mL vials and homogenize using a Precellysin homogenizer. ® (VWR Corporation) pyrolysis 2 Cycle for 30 seconds. Incubate cell-free lysates at 4°C with 12,000 [units of fluid]. Centrifuge further for 15 min. Use the clarified supernatant (cell-free extract) for activity assay.

[0113] Example of this invention: IE6 - ABTS assay - screening for oxidoreductase activity.

[0114] Enzyme activity was measured at 30°C by incubating a cell-free extract (12.5 vol%) in 200 µl of 0.1 M air-saturated potassium phosphate buffer (pH 7.8) containing 5 g / L 2-hydroxy-4-(hydroxy(methyl)phosphono)butanol, 0.2 g / L ABTS (2,2'-azono-bis(3-ethylbenzothiazoline-6-sulfonic acid)), and 0.5 g / L HRP (horseradish peroxidase). The reaction was monitored by measuring the absorbance of ABTSox at 420 nm for up to 2 h. 2-hydroxy-4-(hydroxy(methyl)phosphono)butanol was oxidized in the presence of GalOx-protein (SEQ ID NO:10). 2-hydroxy-4-(hydroxy(methyl)phosphono)butanol was oxidized in the presence of Aox1-protein (SEQ ID NO:4). No oxidation was observed in the absence of the protein.

[0115] Comparison example CE1:

[0116]

[0117] 65 mg of 2-oxo-3-butenoic acid was suspended in 1 mL of dichloromethane. The reaction mixture was heated to 30°C. Subsequently, 100 µL of dichloro(methyl)phosphine was added, and the mixture was stirred at 30°C for 5 hours, then cooled to room temperature. The reaction mixture was then stirred at room temperature for another 15 hours. Afterward, 10 mL of deionized water was added, and the reaction mixture was stirred for 30 min. Then, another 10 mL of dichloromethane was added. The phases were separated, and both phases were concentrated under reduced pressure until dry and analyzed by HPLC. Analysis of the HPLC traces revealed that the starting material was completely consumed, but the desired product was not observed in either phase.

[0118] HPLC method: Aminex HPX-87 H, 300 7.8 mm column, temperature 30°C, flow rate 0.5 mL / min, RI detection, eluent was 5 mM sulfuric acid in water. HPLC retention times: 2-oxo-3-butenoic acid 17.3 min, PPO 9.7 min.

[0119] sequence

[0120] SEQ ID NO:1

[0121]

[0122] SEQ ID NO:2

[0123] MSDITVTNWAGNITYTAKELLRPHSLDALRALVADSARVRVLGSGHSFNEIAEPGDGGVLLSLLAGLPSVVDVDTAARTVRVGGGVRYAELARVVHARGLALPNMASLPHISVAGSVATGTHGSGVGNGSLASVVREVELVTADGSTVVIARGDERFGGAVTSLGALGVVTSLTLDLEPAYEMEQHVFTELPLAGLDPATFETVMAAAYSVSLFTDWRAPGFRQVWLKRRTDRPLDGFPYAAPAAEKMHVPPGMPAVNCTEQFGVPGPWHERLPHFRAEFTPSSGAELQSEYLMPREHALAALHAMDAIRETLAPVLQTCEIRTVAADAQWLSPAYGRDTVAAAHFTWVEDTAAVLPVVRRLEEALVPFAARPHWGKVFTVPAGELRALYPRLADFGALAGALDPAGKFTNAFVRGVLAG

[0124] SEQ ID NO:3

[0125]

[0126] SEQ ID NO:4

[0127] MGHPEEVDVIVCGGGPAGCVVAGRLAYADPTLKVMLIEGGANNRDDPWVYRPGIYVRNMQRNGINDKATFYTDTMASSYLRGRRSIVPCANILGGGSSINFQMYTRASASDWDDFKTEGWTCKDLLPLMKRLENYQKPCNNDTHGYDGPIAISNGGQIMPVAQDFLRAAHAIGVPYSDDIQDLTTAHGAEIWAKYINRHTGRRSDAATAYVHSVMDVQDNLFLRCNARVSRVLFDDNNKAVGVAYVPSRNRTHGGKLHETIVKARKMVVLSSGTLGTPQILERSGVGNGELLRQLGIKIVSDLPGVGEQYQDHYTTLSIYRVSNESITTDDFLRGVKDVQRELFTEWEVSPEKARLSSNAIDAGFKIRPTEEELKEMGPEFNELWNRYFKDKPDKPVMFGSIVAGAYADHTLLPPGKYITMFQYLEYPASRGKIHIKSQNPYVEPFFDSGFMNNKADFAPIRWSYKKTREVARRMDAFRGELTSHHPRFHPASPAACKDIDIETAKQIYPDGLTVGIHMGSWHQPSEPYKHDKVIEDIPYTEEDDKAIDDWVADHVETTWHSLGTCAMKPREQGGVVDKRLNVYGTQNLKCVDLSICPDNLGTNTYSSALLVGEKGADLIAEELGLKIKTPHAPVPHAPVPTGRPATQQVR

[0128] SEQ ID NO:5

[0129]

[0130] SEQ ID NO:6

[0131] MSTSSSDPFFNFAKSSFRSAAAQKASASSLPPLPGPDKKVPGMDIKYDVVIVGSGPIGCTYARELVGAGYKVAMFDIGEIDSGLKIGAHKKNTVEYQKNIDKFVNVIQGQLMSVSVPVNTLVVDTLSPTSWQASTFFVRNGSNPEQDPLRNLSGQAVTRVVGGMSTHWTCATPRFDREQRPLLVKDDADADDAEWDRLYTKAESYFQTGTDQFKESIRHNLVLNKLTEEYKGQRDFQQIPLAATRRSPTFVEWSSANTVFDLQNRPNTDAPEERFNLFPAVACERVVRNALNSEIESLHIHDLISGDRFEIKADVYVLTAGAVHNTQLLVNSGFGQLGRPNPANPPELLPSLGSYITEQSLVFCQTVMSTELIDSVKSDMTIRGTPGELTYSVTYTPGASTNKHPDWWNEKVKNHMMQHQEDPLPIPFEDPEPQVTTLFQPSHPWHTQIHRDAFSYGAVQQSIDSRLIVDWRFFGRTEPKEENKLWFSDKITDAYNMPQPTFDFRFPAGRTSKEAEDMMTDMCVMSAKIGGFLPGSLPQFMEPGLVLHLGGTHRMGFDEKEDNCCVNTDSRVFGFKNLFLGGCGNIPTAYGANPTLTAMSLAIKSCEYIKQNFTPSPFTSEAQ

[0132] SEQ ID NO:7

[0133]

[0134] SEQ ID NO:8

[0135] MSTSSSDPFYNFAKTSFKSAAAQKASATSLPPLPGPDQKVPGMDIKYDVVIVGSGPIGCTYARELVEAGYKVAMFDIGEIDSGLKIGAHKKNTVEYQKNIDKFVNVIQGQLMSVSVPVNKLVVDTLSPTSWQASTFFVRNGSNPEQDPLRNLSGQAVTRVVGGMSTHWTCATPRFDREQRPLLVKDDPDADDAIWDQLYTKAESYFKTGTDQFNESIRHNLVLNKLAEEYKGQRTFQQIPLAATRRNPTFVEWSSANTVFDLQNRPNIDAPEERFNLFPAVACERVMRNASNTAIESLHIRDLISGDRFAIQADVYVLTAGAVHNTQLLVNSGFGKLGRPDPANPPELLPFLGSYITEQSLVFCQTVMSTELIDSVKSDMTIIGNPGELGYSVSYMPGASTNKHPDWWNEKVQNHMMQHQEDPLPIPFEDPEPQVTTLFQPSHPWHTQIHRDAFSYGAVQQSIDSRLIVDWRFFGRTEPKEENKLWFSDKITDAYNMPQPTFDFRFPAGRTSQEAEDMMTDMCVMSAKIGGFLPGSLPQFMEPGLVLHLGGTHRMGFDEQEDNCCVDTDSRVFGFNNLFLGGCGNIPTAYGANPTLTAMSLAIKSCEYIKKNFTPSPFTPAQ

[0136] SEQ ID NO:9

[0137]

[0138] SEQ ID NO:10

[0139] MASAPIGSAISRNNWAVTCDSAQSGNECNKAIDGNKDTFWHTFYGANGDPKPPHTYTIDMKTTQNVNGLSMLPRQDGNQNGWIGRHEVYLSSDGTNWGSPVASGSWFADSTTKYSNFETRPARYVRLVAITEANGQPWTSIAEINVFQASSYTAPQPGLGRWGPTIDLPIVPAAAAIEPTSGRVLMWSSYRNDAFGGSPGGITLTSSWDPSTGIVSDRTVTVTKHDMFCPGISMDGNGQIVVTGGNDAKKTSLYDSSSDSWIPGPDMQVARGYQSSATMSDGRVFTIGGSWSGGVFEKNGEVYSPSSKTWTSLPNAKVNPMLTADKQGLYRSDNHAWLFGWKKGSVFQAGPSTAMNWYYTSGSGDVKSAGKRQSNRGVAPDAMCGNAVMYDAVKGKILTFGGSPDYQDSDATTNAHIITLGEPGTSPNTVFASNGLYFARTFHTSVVLPDGSTFITGGQRRGIPFEDSTPVFTPEIYVPEQDTFYKQNPNSIVRVYHSISLLLPDGRVFNGGGGLCGDCTTNHFDAQIFTPNYLYNSNGNLATRPKITRTSTQSVKVGGRITISTDSSISKASLIRYGTATHTVNTDQRRIPLTLTNNGGNSYSFQVPSDSGVALPGYWMLFVMNSAGVPSVASTIRVTQ。

Claims

1. A method for preparing 2-oxo-4-(hydroxy(methyl)phosphono)butyric acid (PPO) having formula (I). (I) The method includes oxidizing a diol having formula (IIa) in an oxidation step: (IIa), And / or hydroxymethyl ketones according to formula (IIb): (IIb)。 2. The method according to claim 1, wherein, This oxidation step is carried out in the presence of a chemical catalyst or enzyme.

3. The method according to claim 2, wherein, The oxidation step is carried out in the presence of an enzyme, wherein the enzyme is an oxidoreductase EC1, preferably an oxidoreductase EC1 selected from the group consisting of EC1.1, EC1.2 and EC1.10, and more preferably an oxidoreductase EC1 selected from the group consisting of EC1.1.1, EC1.1.3, EC1.2.1 and EC1.2.

3.

4. The method according to claim 1, wherein, The oxidation step is carried out in the presence of a chemical catalyst, wherein the chemical catalyst is a platinum group metal catalyst, and the oxidation step is further carried out in the presence of a gas containing molecular oxygen and an activator.

5. The method according to claim 4, wherein, The activator comprises one or more compounds selected from the group consisting of lead in elemental form, bismuth in elemental form, lead in oxide form, bismuth in oxide form, lead in hydrochloride form, bismuth in hydrochloride form, lead in the form of an inorganic oxyacid salt, bismuth in the form of an inorganic oxyacid salt, lead in the form of a transition metal oxyacid salt, bismuth in the form of a transition metal oxyacid salt, lead in the form of an organic aliphatic or aromatic acid salt, and bismuth in the form of an organic aliphatic or aromatic acid salt, preferably selected from lead in elemental form and bismuth in elemental form, and most preferably bismuth in elemental form.

6. The method according to any one of claims 4 to 5, wherein, The platinum group metal catalyst is selected from platinum and palladium.

7. The method according to any one of claims 4 to 6, wherein, The activator was incorporated into the platinum group metal catalyst.

8. The method according to any one of claims 4 to 7, wherein, This platinum group metal catalyst is a supported catalyst, preferably a carbon-supported catalyst.

9. The method according to any one of claims 4 to 8, wherein, The method is carried out at a temperature of 10°C to 100°C, preferably 25°C to 85°C, and most preferably 45°C to 65°C.

10. The method according to any one of claims 1 to 8, wherein, This oxidation step takes place in the presence of catalase.

11. The method according to claim 10, wherein, The method is carried out at a temperature of 25°C to 45°C, preferably 30°C to 42°C, and most preferably 35°C to 40°C.

12. The method according to any one of claims 4 to 11, wherein, This method is carried out using a gas containing molecular oxygen at a pressure of 0.5-10 atmospheres.

13. Uses comprising the following mixtures for the preparation of glufosinate and / or glufosinate salts, more particularly glufosinate, glufosinate sodium or glufosinate ammonium: 2-oxo-4-(hydroxy(methyl)phosphono)butyric acid (PPO) according to formula (I): (I), And additionally, diols according to formula (IIa): And / or hydroxymethyl ketones according to formula (IIb): (IIb)。 14. A mixture comprising 2-oxo-4-(hydroxy(methyl)phosphono)butyric acid (PPO) according to formula (I): (I), And additionally, diols according to formula (IIa): (IIa), And / or hydroxymethyl ketones according to formula (IIb): (IIb)。

Citation Information

Patent Citations

  • New nucleic acid sequence encoding Alcaligenes faecalis nitrilase polypeptide useful for converting racemic nitriles to chiral carboxylic acids

    DE19848129A1

  • Derivatives of 4-(methylphosphinyl)-2-oxobutanoic acid, herbicidal compositions containing them, and intermediates and methods for their production

    EP0030424B1

  • L-rhamnose-inducible expression systems

    WO2004050877A1

  • Biocatalytic production of l-fucose

    WO2016150629A1

  • Methods for making l-glufosinate

    WO2017151573A1